Tharimmune, Inc. — Investor Relations & Filings
Filings indexed
286
across all filing types
Latest filing
2026-05-13
Interim / Quarterly Rep…
Country
US
United States of America
Listing
US
THAR
Tharimmune, Inc. is a clinical-stage biotechnology company developing a portfolio of therapeutic candidates for immunology, inflammation, and oncology. The company's pipeline includes TH104, a product candidate for treating pruritus in primary biliary cholangitis (PBC), and treatments for solid tumors that target mechanisms such as ferroptosis. In addition to its biotechnology research and development, the company is also involved in activities supporting institutional blockchain adoption and the digitization of financial markets through the Canton Network.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| 10-Q - Canton Strategic Holdings, Inc. (0001861657) (Filer) | 2026-05-13 | English | |
| 10-K - Canton Strategic Holdings, Inc. (0001861657) (Filer) | 2026-03-31 | English | |
| 8-K - Canton Strategic Holdings, Inc. (0001861657) (Filer) | 2026-03-31 | English | |
| 8-K - THARIMMUNE, INC. (0001861657) (Filer) | 2026-03-03 | English | |
| 8-K - THARIMMUNE, INC. (0001861657) (Filer) | 2026-03-03 | English | |
| 8-K Filing | 2026-02-18 | English |
Browse filings by year
6 years| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2026
15 filings
| |||||
| 45602861 | 10-Q - Canton Strategic Holdings, Inc. (0001861657) (Filer) | 2026-05-13 | English | ||
| 33115786 | 10-K - Canton Strategic Holdings, Inc. (0001861657) (Filer) | 2026-03-31 | English | ||
| 33114948 | 8-K - Canton Strategic Holdings, Inc. (0001861657) (Filer) | 2026-03-31 | English | ||
| 32900013 | 8-K - THARIMMUNE, INC. (0001861657) (Filer) | 2026-03-03 | English | ||
| 32900012 | 8-K - THARIMMUNE, INC. (0001861657) (Filer) | 2026-03-03 | English | ||
| 32108846 | 8-K Filing | 2026-02-18 | English | ||
| 32108942 | 3 Filing | 2026-02-11 | English | ||
| 32108799 | 3 Filing | 2026-02-11 | English | ||
| 32108723 | 3 Filing | 2026-02-11 | English | ||
| 32108716 | 3 Filing | 2026-02-11 | English | ||
| 32108766 | 8-K Filing | 2026-02-06 | English | ||
| 32108719 | SCHEDULE 13G Filing | 2026-02-03 | English | ||
| 32108757 | 8-K Filing | 2026-02-02 | English | ||
| 32108728 | SCHEDULE 13G Filing | 2026-02-02 | English | ||
| 13453399 | DEFA14A | 2026-01-26 | English | ||
Market data
Market data not available
Last price
Market cap
volume
Day range
today
52-week range
trailing
Price history
Peer group · Manufacture of pharmaceuticals, medicinal chemical and botanical products
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
BY-HEALTH CO.,LTD
Researches, develops, and distributes dietary supplements, …
|
300146 | CN | Manufacturing |
|
C4 Therapeutics, Inc.
Clinical-stage biopharma developing targeted protein degrad…
|
CCCC | US | Manufacturing |
|
Cadrenal Therapeutics, Inc.
A late-stage biopharmaceutical company developing novel ant…
|
CVKD | US | Manufacturing |
|
CalciMedica, Inc.
Develops CRAC channel inhibitors for acute inflammatory and…
|
CALC | US | Manufacturing |
|
Calidi Biotherapeutics, Inc.
Develops stem cell platforms to deliver oncolytic viruses f…
|
CLDI | US | Manufacturing |
|
Calliditas Therapeutics
Biopharma company developing and commercializing treatments…
|
CALTX | SE | Manufacturing |
|
Callitas Health Inc.
Clinical-stage biomedical company developing pharma and OTC…
|
MPHMF | CA | Manufacturing |
|
CALTH. Inc
Develops in vitro diagnostic tools for point-of-care and se…
|
402420 | KR | Manufacturing |
|
Cambrex
A CDMO providing drug substance, drug product, and analytic…
|
CBM | US | Manufacturing |
|
CAMBRIDGE NUTRITIONAL SCIENCES PLC
Develops and manufactures diagnostic tests for food sensiti…
|
CNSL | GB | Manufacturing |
Tharimmune, Inc. via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/34824/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=34824 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=34824 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
Full reference: API reference · OpenAPI schema
cURL
$ curl https://api.financialreports.eu/api/filings/?company=34824 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 34824}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for Tharimmune, Inc. (id: 34824)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.
We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.